Back to TVTX

Vestal Point Capital, LP → TVTX

Vestal Point Capital, LP TVTX Position History

Travere Therapeutics, Inc. • Healthcare

Quarters held
1
Latest value
$35.3M
Q3 2026
Peak value
$35.3M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$35.3M600.0K——

Other funds holding TVTX

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M